Empagliflozin + carvedilol
- 1 lab in 1 country
- Funder: Chong Kun Dang Pharmaceutical
- Human trial1
Outcomes
1Vena contracta width
downin humans1
1 study
Vena contracta width
downin humans1
Empagliflozin + carvedilol decreases vena contracta width in humans (-0.78 ± 1.15 mm vs. 0.56 ± 1.45 mm, P = 0.03).
Human trialfunctional tricuspid regurgitation
Journal of cardiovascular imaging14 Sep 2026
Latest
1 in 12 monthsJournal of Cardiovascular Imaging
Effect of empagliflozin with or without carvedilol on tricuspid regurgitation and right ventricular remodeling: PROVE trial
Randomised trial in 56 peopleEmpagliflozin